Please ensure JavaScript is enabled for purposes of website accessibility

NEWS: Amgen completes acquisition of Horizon Therapeutics. Read press release.

U.S.

  • Global
    • BrazilBrazil
    • CanadaCanada
    • GermanyGermany
    • JapanJapan
Horizon logo
  • Our Company
    • Grant Programs
    • Contact Us
  • Our Science
    • Pipeline
    • Clinical Trials
  • Our Medicines
    • Our Portfolio
    • Medical Resources
  • Our Patients
    • Patient Support
    • Expanded Access
  • Careers
    • Join Our Team
    • Job Opportunities

Video Library

Dazodalibep (HZN-4920) Mechanism of Action

Dazodalibep (HZN-4920) Mechanism of Action

Dazodalibep (HZN-4920) Mechanism of Action

  • Our Company
  • Our Science
  • Our Medicines
  • Our Patients
  • Careers

© 2023 Horizon Therapeutics plc

  • Global Privacy Policy
  • Legal Notice
  • Cookie Policy
  • Contact Us

The information regarding our medicines and the patients they treat on this site is intended only for residents of the U.S.

You are leaving HorizonTherapeutics.com You are leaving HorizonTherapeutics.com. You will be redirected to a website operated by an independent third party. This link is provided solely for your convenience. You are leaving HorizonTherapeutics.com You are about to go to another website that is operated by Horizon. Would you like to continue? You are leaving HorizonTherapeutics.com You will be directed to a product website to learn more about a medicine for Horizon. You are leaving HorizonTherapeutics.com You are being directed to a site owned by Amgen (content coming)

Leaving Site

Cancel Continue